Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Inv. presentation

Entasis Therapeutics Holdings Inc. (ETTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/11/2022 4 Wagner Kristie Ann (VP, Principal Fin & Acct Off) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 80,500 shares @ $0
Disposed of 73,400 options to buy @ $2.4, valued at $176.2k
07/11/2022 4 Triola Anna Diaz (Chief Commercial Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 125,000 shares @ $0
Disposed of 100,000 options to buy @ $2.49, valued at $249k
07/11/2022 4 Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Unknown transaction of 39,596 shares @ $2.2, valued at $87.1k
Disposed/sold 150,000 shares @ $0
Disposed of 98,700 options to buy @ $2.44, valued at $240.8k
Disposed of 50,000 options to buy @ $4.94, valued at $247k
Disposed of 24,858 options to buy @ $3.11, valued at $77.3k
Disposed of 6,465 options to buy @ $3.74, valued at $24.2k
07/11/2022 4 Ronsheim Matthew (Chief of Pharma Sciences & MFG) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Unknown transaction of 17,572 shares @ $2.2, valued at $38.7k
Disposed/sold 150,000 shares @ $0
Disposed of 33,333 options to buy @ $2.44, valued at $81.3k
Disposed of 20,000 options to buy @ $2.86, valued at $57.2k
Disposed of 15,000 options to buy @ $4.7, valued at $70.5k
Disposed of 20,000 options to buy @ $4.8, valued at $96k
07/11/2022 4 Perros Manoussos (President and CEO) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Unknown transaction of 56,072 shares @ $2.2, valued at $123.4k
Disposed/sold 478,500 shares @ $0
Disposed of 325,755 options to buy @ $2.44, valued at $794.8k
Disposed of 145,000 options to buy @ $4.94, valued at $716.3k
Disposed of 183,013 options to buy @ $3.11, valued at $569.2k
Disposed of 69,970 options to buy @ $3.74, valued at $261.7k
07/11/2022 4 Mueller John Patrick (Chief Development Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Unknown transaction of 17,092 shares @ $2.2, valued at $37.6k
Disposed/sold 150,000 shares @ $0
Disposed of 75,698 options to buy @ $2.44, valued at $184.7k
Disposed of 50,000 options to buy @ $4.94, valued at $247k
Disposed of 25,092 options to buy @ $3.11, valued at $78k
Disposed of 18,253 options to buy @ $3.74, valued at $68.3k
07/11/2022 4 Meek David D. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Unknown transaction of 22,000 shares @ $2.2, valued at $48.4k
Disposed/sold 27,500 shares @ $2.2, valued at $60.5k
Disposed of 17,307 options to buy @ $2.44, valued at $42.2k
Disposed of 11,000 options to buy @ $2.98, valued at $32.8k
07/11/2022 4 Mayer Howard (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Unknown transaction of 22,000 shares @ $2.2, valued at $48.4k
Disposed/sold 27,500 shares @ $2.2, valued at $60.5k
Disposed of 12,500 options to buy @ $2.44, valued at $30.5k
Disposed of 11,000 options to buy @ $2.98, valued at $32.8k
07/11/2022 4 Keiley Elizabeth M (General Counsel) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Unknown transaction of 17,572 shares @ $2.2, valued at $38.7k
Disposed/sold 150,000 shares @ $0
Disposed of 20,833 options to buy @ $2.44, valued at $50.8k
Disposed of 50,000 options to buy @ $2.94, valued at $147k
07/11/2022 4 HASTINGS DAVID C (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Unknown transaction of 22,000 shares @ $2.2, valued at $48.4k
Disposed/sold 27,500 shares @ $2.2, valued at $60.5k
Disposed of 26,583 options to buy @ $2.44, valued at $64.9k
Disposed of 11,000 options to buy @ $2.98, valued at $32.8k
07/11/2022 4 Berger Heather A. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Unknown transaction of 22,000 shares @ $2.2, valued at $48.4k
Disposed/sold 27,500 shares @ $2.2, valued at $60.5k
Disposed of 17,307 options to buy @ $2.44, valued at $42.2k
Disposed of 11,000 options to buy @ $2.98, valued at $32.8k
07/11/2022 4 Altarac David (Chief Medical Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Unknown transaction of 17,572 shares @ $2.2, valued at $38.7k
Disposed/sold 150,000 shares @ $0
Disposed of 92,307 options to buy @ $2.44, valued at $225.2k
Disposed of 50,000 options to buy @ $4.94, valued at $247k
02/25/2022 4 Wagner Kristie Ann (VP, Principal Fin & Acct Off) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 10,000 shares @ $0
02/23/2022 4 Innoviva, Inc. (10% Owner) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Acquired options to buy @ $1.48, valued at $0
Acquired options to buy @ $1.48, valued at $0
02/15/2022 4 Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 22,816 options to buy @ $4.98, valued at $113.6k
Granted 15,210 options to buy @ $2.44, valued at $37.1k
Disposed/sold 15,632 options to buy @ $6.85, valued at $107.1k
Granted 12,024 options to buy @ $2.44, valued at $29.3k
Disposed/sold 50,411 options to buy @ $15, valued at $756.2k
Granted 28,006 options to buy @ $2.44, valued at $68.3k
Disposed/sold 56,500 options to buy @ $5.66, valued at $319.8k
Granted 43,460 options to buy @ $2.44, valued at $106k
02/15/2022 4 Gutch Michael (See Remarks) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 30,006 options to buy @ $6.85, valued at $205.5k
Granted 23,081 options to buy @ $2.44, valued at $56.3k
Disposed/sold 15,956 options to buy @ $15, valued at $239.3k
Granted 8,863 options to buy @ $2.44, valued at $21.6k
Disposed/sold 56,500 options to buy @ $5.66, valued at $319.8k
Granted 43,460 options to buy @ $2.44, valued at $106k
02/15/2022 4 Ronsheim Matthew (See Remarks) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 40,000 options to buy @ $5.12, valued at $204.8k
Granted 33,333 options to buy @ $2.44, valued at $81.3k
02/15/2022 4 Perros Manoussos (President and CEO) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 87,462 options to buy @ $4.98, valued at $435.6k
Granted 58,307 options to buy @ $2.44, valued at $142.3k
Disposed/sold 166,623 options to buy @ $6.85, valued at $1.1M
Granted 128,531 options to buy @ $2.44, valued at $313.6k
Disposed/sold 79,698 options to buy @ $15, valued at $1.2M
Granted 44,276 options to buy @ $2.44, valued at $108k
Disposed/sold 123,500 options to buy @ $5.66, valued at $699k
Granted 95,000 options to buy @ $2.44, valued at $231.8k
02/15/2022 4 Mueller John Patrick (Chief Development Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 22,816 options to buy @ $4.98, valued at $113.6k
Granted 15,210 options to buy @ $2.44, valued at $37.1k
Disposed/sold 16,892 options to buy @ $6.85, valued at $115.7k
Granted 12,993 options to buy @ $2.44, valued at $31.7k
Disposed/sold 7,265 options to buy @ $15, valued at $109k
Granted 4,035 options to buy @ $2.44, valued at $9.8k
Disposed/sold 56,500 options to buy @ $5.66, valued at $319.8k
Granted 43,460 options to buy @ $2.44, valued at $106k
02/15/2022 4 Mayer Howard (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 15,000 options to buy @ $6.44, valued at $96.6k
Granted 12,500 options to buy @ $2.44, valued at $30.5k
02/15/2022 4 Meek David D. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 15,000 options to buy @ $6.12, valued at $91.8k
Granted 11,538 options to buy @ $2.44, valued at $28.2k
Disposed/sold 7,500 options to buy @ $6.12, valued at $45.9k
Granted 5,769 options to buy @ $2.44, valued at $14.1k
02/15/2022 4 Behanna Heather (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 15,000 options to buy @ $5.66, valued at $84.9k
Granted 11,538 options to buy @ $2.44, valued at $28.2k
Disposed/sold 7,500 options to buy @ $6.12, valued at $45.9k
Granted 5,769 options to buy @ $2.44, valued at $14.1k
02/15/2022 4 Altarac David (Chief Medical Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 120,000 options to buy @ $5.7, valued at $684k
Granted 92 options to buy @ $2.44, valued at $225.2
02/15/2022 4 HASTINGS DAVID C (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 12,060 options to buy @ $6.85, valued at $82.6k
Granted 9,276 options to buy @ $2.44, valued at $22.6k
Disposed/sold 15,000 options to buy @ $5.66, valued at $84.9k
Granted 11,538 options to buy @ $2.44, valued at $28.2k
Disposed/sold 7,500 options to buy @ $6.12, valued at $45.9k
Granted 5,769 options to buy @ $2.44, valued at $14.1k
02/15/2022 4 Keiley Elizabeth M (General Counsel) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 25,000 options to buy @ $6.9, valued at $172.5k
Granted 20,833 options to buy @ $2.44, valued at $50.8k
01/19/2022 4 Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 125,000 shares @ $0
01/19/2022 4 Gutch Michael (See Remarks) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 125,000 shares @ $0
01/19/2022 4 Ronsheim Matthew (See Remarks) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 125,000 shares @ $0
01/19/2022 4 Perros Manoussos (See Remarks) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 125,000 shares @ $0
01/19/2022 4 Mueller John Patrick (Chief Development Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 125,000 shares @ $0
01/19/2022 4 Mayer Howard (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 27,500 shares @ $0
01/19/2022 4 Behanna Heather (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 27,500 shares @ $0
01/19/2022 4 Keiley Elizabeth M (General Counsel) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 125,000 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy